|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
|
|---|---|---|---|---|---|---|
| Current assets | ||||||
| Cash | ||||||
| Due from Sponsor | ||||||
| Prepaid expense | ||||||
| Prepaid insurance | ||||||
| Total current assets | ||||||
| Deferred offering costs | ||||||
| Long-term prepaid insurance | ||||||
| Cash and investments held in Trust Account | ||||||
| Total Assets | ||||||
| Current Liabilities | ||||||
| Accrued offering costs | ||||||
| Accrued expenses | ||||||
| Accounts payable and accrued expenses | ||||||
| Due to affiliates | ||||||
| Promissory note - related party | ||||||
| Related Party | ||||||
| Total promissory note - related party | ||||||
| Total current liabilities | ||||||
| Deferred underwriting fee payable | ||||||
| Total Liabilities | ||||||
| Class A ordinary shares subject to possible redemption, 23,000,000 shares issued and outstanding at a redemption value of $10.33 and $10.24 per share as of March 31, 2026 and December 31, 2025, respectively | ||||||
| Shareholders’ Deficit | ||||||
| Ordinary shares value | ||||||
| Class A Ordinary Shares | ||||||
| Class B Ordinary Shares | ||||||
| Additional paid-in capital | ||||||
| Accumulated deficit | ||||||
| Class B Ordinary Shares | ||||||
| Total accumulated deficit | ||||||
| Total Shareholders’ Deficit | ||||||
| Total Liabilities and Shareholders’ Deficit |
Loading...
